CHICAGO – Roche is terminating its precision medicine partnership with software developer Syapse later this month, the pharmaceutical and diagnostics giant confirmed Friday. The deal will end Dec. 18, less than two years after it began, a company spokesperson said.
"As partnerships evolve, priorities and timelines can change, resulting in a reassessment of where to focus resources," Roche spokesperson Patrick Barth told GenomeWeb via email.